Stocks / NASDAQ / REGENXBIO Inc.

REGENXBIO Inc.

Industry:   Health Care - Biotechnology: Biological Products (No Diagnostic Substances) Stock Symbol:   RGNX - NASDAQ Animal Usage:   Animal Testing

Our Opinion

REGENXBIO Inc is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and therapies.

Supporting Evidence:

The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.

“We believe our NAV Technology Platform is proving to be a significant advancement over earlier AAV vectors in delivering these therapies. Based on data derived from third-party clinical studies and animal models using our NAV Vectors, we believe our NAV Technology Platform possesses unique, beneficial properties that are not seen in earlier generation AAVs.” Read the following article

Company Description

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD. [Source: MarketWatch]

Company Website: http://www.regenxbio.com

Contact:   http://www.regenxbio.com/pages/contact/contact.htm; IR: ir@regenxbio.com;